Follicular Lymphoma
News
Obinutuzumab approved to treat FL in Canada
Health Canada has approved the use of obinutuzumab (Gazyva®), an anti-CD20 monoclonal antibody, in patients with follicular lymphoma (FL).
From the Journals
Circulating DNA catches lymphoma relapse early
New findings from researchers at Stanford signal a win for ‘liquid biopsy,’ the measurement of tumor DNA circulating in the blood.
News
Study provides new insight into B-cell metabolism
Research published in Nature Immunology helps explain how B-cell metabolism adapts to different environments.
Conference Coverage
Combined checkpoint blockade promising in HL
SAN DIEGO—Immune checkpoint blockade with nivolumab plus ipilimumab has shown promise in treating hematologic malignancies, particularly classical...
News
JCAR017 gets PRIME access, breakthrough designation
The chimeric antigen receptor (CAR) T-cell therapy JCAR017 has received breakthrough therapy designation from the US Food and Drug Administration...
Conference Coverage
CAR met primary endpoint at interim analysis in DLBCL
2016 ASH Annual Meeting SAN DIEGO—The chimeric antigen receptor (CAR) T-cell therapy KTE-C19 has met its primary endpoint at the pre-specified...
News
Characterizing FL transformation, progression
Patients with transformed follicular lymphoma (FL) and FL patients with early progression have “widely divergent patterns of clonal dynamics,”...
Conference Coverage
VIDEO: Obinutuzumab bests rituximab for PFS in follicular lymphoma
SAN DIEGO – For patients with indolent non-Hodgkin lymphoma, adding rituximab to a standard-combination chemotherapy regimen resulted in...
Conference Coverage
Antibody face-off in follicular lymphoma gives PFS, but not OS, edge to obinutuzumab
SAN DIEGO – Obinutuzumab, a second-generation anti-CD20 antibody touted as the heir apparent to rituximab, offered a PFS edge over rituximab when...
News
Tazemetostat receives fast track designation for DLBCL
The US Food and Drug Administration (FDA) has granted fast track designation for tazemetostat as a treatment for patients with relapsed or...
News
Blood test can predict outcomes in DLBCL, team says
Photo by Juan D.